Download PDF
Semin Liver Dis 2019; 39(02): 178-194
DOI: 10.1055/s-0039-1678726
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Balloon Tamponade and Esophageal Stenting for Esophageal Variceal Bleeding in Cirrhosis: A Systematic Review and Meta-analysis

Susana G. Rodrigues
1   Swiss Liver Center, UVCM, Inselspital, Bern University Hospital, Department of Biomedical Research, University of Bern, Bern, Switzerland
,
Andrés Cárdenas
2   GI/Liver Unit, Institute of Digestive Diseases and Metabolism, University of Barcelona, Barcelona, Spain
4   Institut d'Investigacions Biomèdiques August-Pi-Sunyer (IDIBAPS), Barcelona, Spain
,
Àngels Escorsell
3   Liver Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain
4   Institut d'Investigacions Biomèdiques August-Pi-Sunyer (IDIBAPS), Barcelona, Spain
5   Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain
,
Jaime Bosch
1   Swiss Liver Center, UVCM, Inselspital, Bern University Hospital, Department of Biomedical Research, University of Bern, Bern, Switzerland
4   Institut d'Investigacions Biomèdiques August-Pi-Sunyer (IDIBAPS), Barcelona, Spain
› Author Affiliations
Further Information

Publication History

Publication Date:
25 March 2019 (online)

    Permissions and Reprints

Abstract

Failure to control variceal bleeding with current recommendations occurs in 10 to 20% of cases. This systematic review and meta-analysis analyzes the experience, results, and complications of “bridge” therapies for failure to control acute variceal bleeding: balloon tamponade and esophageal stents. The main outcomes assessed were failure to control bleeding and mortality in the short-term and medium-term follow-up, and adverse events. Balloon tamponade studies had a pooled rate of short-term failure to control bleeding of 35.5%, and adverse events in over 20% of cases; 9.7% resulting in death. Stenting failed to control bleeding in the short term and medium term in 12.7 and 21.5% of cases of severe or refractory variceal bleeding, respectively, despite stent migration in 23.8% of cases. Medium-term mortality rates were similar in both therapies. Although only one trial compared these treatments, the available evidence consistently supports that stents serve as a better and safer bridge therapy in refractory acute variceal bleeding.

Keywords

cirrhosis - esophageal varices - refractory variceal bleeding - self-expanding metallic stent - Sengstaken-Blakemore tube

Supplementary Material

 

  • References

  • 1 North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988; 319 (15) 983-989
    CrossrefPubMedGoogle Scholar
  • 2 Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010; 362 (09) 823-832
    CrossrefPubMedGoogle Scholar
  • 3 D'Amico G, De Franchis R. ; Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38 (03) 599-612
    PubMedGoogle Scholar
  • 4 Reverter E, Tandon P, Augustin S. , et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology 2014; 146 (02) 412-19.e3
    CrossrefPubMedGoogle Scholar
  • 5 Moitinho E, Escorsell A, Bandi JC. , et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999; 117 (03) 626-631
    CrossrefPubMedGoogle Scholar
  • 6 Bosch J, Berzigotti A. Portal hypertension in cirrhosis. In: Dooley J, Lok A, Garcia-Tsao G, Pinzani M. , eds. Sherlock's Diseases of the Liver and Biliary System. Hoboken, NJ: Wiley-Blackwell; 2018: 180-208
    Google Scholar
  • 7 Abraldes JG, Villanueva C, Bañares R. , et al; Spanish Cooperative Group for Portal Hypertension and Variceal Bleeding. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 2008; 48 (02) 229-236
    CrossrefPubMedGoogle Scholar
  • 8 Bureau C, Garcia-Pagan JC, Otal P. , et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126 (02) 469-475
    CrossrefPubMedGoogle Scholar
  • 9 Escorsell A, Bañares R, García-Pagán JC. , et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 2002; 35 (02) 385-392
    CrossrefPubMedGoogle Scholar
  • 10 García-Pagán JC, Caca K, Bureau C. , et al; Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362 (25) 2370-2379
    CrossrefPubMedGoogle Scholar
  • 11 Hernández-Gea V, Procopet B, Giráldez Á. , et al; International Variceal Bleeding Observational Study Group and Baveno Cooperation. Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study. Hepatology 2019; 69 (01) 282-293
    PubMedGoogle Scholar
  • 12 de Franchis R. Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63 (03) 743-752
    CrossrefPubMedGoogle Scholar
  • 13 Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017; 65 (01) 310-335
    CrossrefPubMedGoogle Scholar
  • 14 Moher D, Liberati A, Tetzlaff J, Altman DG. ; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62 (10) 1006-1012
    CrossrefPubMedGoogle Scholar
  • 15 de Franchis R. Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53 (04) 762-768
    CrossrefPubMedGoogle Scholar
  • 16 Wells GA, Shea B, O'Connell D. , et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses [2009]. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm . Accessed March 7, 2018
    PubMed
  • 17 Escorsell A, Bosch J. Self-expandable metal stents in the treatment of acute esophageal variceal bleeding. Gastroenterol Res Pract 2011; 2011: 910986
    PubMedGoogle Scholar
  • 18 Copenhagen Esophageal Varices Sclerotherapy Project. Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. N Engl J Med 1984; 311 (25) 1594-1600
    CrossrefPubMedGoogle Scholar
  • 19 Pinto Correia J, Martins Alves M, Alexandrino P, Silveira J. Controlled trial of vasopressin and balloon tamponade in bleeding esophageal varices. Hepatology 1984; 4 (05) 885-888
    CrossrefPubMedGoogle Scholar
  • 20 Paquet KJ, Feussner H. Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology 1985; 5 (04) 580-583
    CrossrefPubMedGoogle Scholar
  • 21 Larson AW, Cohen H, Zweiban B. , et al. Acute esophageal variceal sclerotherapy. Results of a prospective randomized controlled trial. JAMA 1986; 255 (04) 497-500
    CrossrefPubMedGoogle Scholar
  • 22 Panés J, Terés J, Bosch J, Rodés J. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci 1988; 33 (04) 454-459
    CrossrefPubMedGoogle Scholar
  • 23 Terés J, Planas R, Panes J. , et al. Vasopressin/nitroglycerin infusion vs. esophageal tamponade in the treatment of acute variceal bleeding: a randomized controlled trial. Hepatology 1990; 11 (06) 964-968
    CrossrefPubMedGoogle Scholar
  • 24 Fort E, Sautereau D, Silvain C, Ingrand P, Pillegand B, Beauchant M. A randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control of acute variceal hemorrhage. Hepatology 1990; 11 (04) 678-681
    CrossrefPubMedGoogle Scholar
  • 25 Avgerinos A, Klonis C, Rekoumis G, Gouma P, Papadimitriou N, Raptis S. A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhage. J Hepatol 1991; 13 (01) 78-83
    CrossrefPubMedGoogle Scholar
  • 26 Jaramillo JL, de la Mata M, Miño G, Costán G, Gómez-Camacho F. Somatostatin versus Sengstaken balloon tamponade for primary haemostasia of bleeding esophageal varices. A randomized pilot study. J Hepatol 1991; 12 (01) 100-105
    CrossrefPubMedGoogle Scholar
  • 27 McKee RF, Garden OJ, Anderson JR, Carter DC. A comparison of SMS 201-995 and oesophageal tamponade in the control of acute variceal haemorrhage. HPB Surg 1992; 6 (01) 7-17
    CrossrefPubMedGoogle Scholar
  • 28 Escorsell À, Pavel O, Cárdenas A. , et al; Variceal Bleeding Study Group. Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: a multicenter randomized, controlled trial. Hepatology 2016; 63 (06) 1957-1967
    CrossrefPubMedGoogle Scholar
  • 29 Choi JY, Jo YW, Lee SS. , et al. Outcomes of patients treated with Sengstaken-Blakemore tube for uncontrolled variceal hemorrhage. Korean J Intern Med 2018; 33 (04) 696-704
    CrossrefPubMedGoogle Scholar
  • 30 Hubmann R, Bodlaj G, Czompo M. , et al. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy 2006; 38 (09) 896-901
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Zehetner J, Shamiyeh A, Wayand W, Hubmann R. Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent. Surg Endosc 2008; 22 (10) 2149-2152
    CrossrefPubMedGoogle Scholar
  • 32 Wright G, Lewis H, Hogan B, Burroughs A, Patch D, O'Beirne J. A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center. Gastrointest Endosc 2010; 71 (01) 71-78
    CrossrefPubMedGoogle Scholar
  • 33 Dechêne A, El Fouly AH, Bechmann LP. , et al. Acute management of refractory variceal bleeding in liver cirrhosis by self-expanding metal stents. Digestion 2012; 85 (03) 185-191
    CrossrefPubMedGoogle Scholar
  • 34 Zakaria MS, Hamza IM, Mohey MA, Hubamnn RG. The first Egyptian experience using new self-expandable metal stents in acute esophageal variceal bleeding: pilot study. Saudi J Gastroenterol 2013; 19 (04) 177-181
    CrossrefPubMedGoogle Scholar
  • 35 Fierz FC, Kistler W, Stenz V, Gubler C. Treatment of esophageal variceal hemorrhage with self-expanding metal stents as a rescue maneuver in a Swiss multicentric cohort. Case Rep Gastroenterol 2013; 7 (01) 97-105
    CrossrefPubMedGoogle Scholar
  • 36 Müller M, Seufferlein T, Perkhofer L, Wagner M, Kleger A. Self-expandable metal stents for persisting esophageal variceal bleeding after band ligation or injection-therapy: a retrospective study. PLoS One 2015; 10 (06) e0126525
    CrossrefPubMedGoogle Scholar
  • 37 Drastich P, Brezina J, Frankova S, Sperl J, Spicak J. Treatment of uncontrollable acute variceal bleeding with self-expanding metal stent: a single center experience. Paper presented at: Baveno VI Consensus Workshop Stratifying Risk and Individualizing Care for Portal Hypertension; April 11, 2015 ; Baveno
    PubMedGoogle Scholar
  • 38 Pfisterer N, Dolak W, Pachofsky T. , et al. Outcome after SX-ELLA Danis bleeding stent implantation for refractory variceal bleeding in patients with cirrhosis – a Vienna Multicenter Experience. Paper presented at: The International Liver Congress; April 12, 2018 ; Paris
    PubMed
  • 39 Maiwall R, Jamwal KD, Bhardwaj A. , et al. SX-Ella Stent Danis effectively controls refractory variceal bleed in patients with acute-on-chronic liver failure. Dig Dis Sci 2018; 63 (02) 493-501
    CrossrefPubMedGoogle Scholar
  • 40 Marot A, Trépo E, Doerig C, Moreno C, Moradpour D, Deltenre P. Systematic review with meta-analysis: self-expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding. Aliment Pharmacol Ther 2015; 42 (11-12): 1250-1260
    CrossrefPubMedGoogle Scholar
  • 41 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018; 69 (02) 406-460
    CrossrefPubMedGoogle Scholar